Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF with Bortezomib, Cyclophosphamide, and Dexamethasone in Multiple Myeloma
NCT02027220Phase 2Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Dec 2013
- Primary completion
- Dec 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in multiple myeloma (MM), sponsored by The Second Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
filgrastim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02027220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027220.